Mark D. Perrin

Mark D.
Perrin formerly worked at ConjuChem Biotechnologies, Inc., as President & Chief Executive Officer from 2005 to 2009, InVivo Therapeutics Corp., as Chairman & Chief Executive Officer, ConjuChem Biotechnologies, Inc., as President & Chief Executive Officer in 2005, Invivo Therapeutics Holdings Corp., as Chairman & Chief Executive Officer from 2014 to 2017, COR Therapeutics, Inc., as Executive Vice President-Commercial Operations from 1995 to 2001, Orphan Medical, Inc., as Chief Commercial Officer & Executive VP from 2002 to 2005, Lederle Laboratories, as Division Manager-Lederle Canada, Burroughs Wellcome, as Vice President-Marketing & Sales, and Dennan Consulting, as President.
Mr. Perrin received his undergraduate degree from Fordham University and Masters Business Admin degree from Kellogg School of Management.